1R-(15)-(15)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Name1R-(15)-(15)

Drug Alias Namehumanized anti-IGF-1R-hMN-15 bispecific antibody

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Monoclonal antibody conjugateBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody conjugateBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionCarcinoembryonic antigen related cell adhesion molecule 6 inhibitorsInsulin-like growth factor I receptor modulators

TargetsInsulin-like growth factor I receptorCarcinoembryonic antigen related cell adhesion molecule 6

Therapy Area/IndicationsSolid tumours

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesImmunomedics Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesImmunomedics Inc

Active IndicationsN/A

Inactive IndicationsSolid tumours

Other Information

ATC CodeN/A